Heart pump patients to test Smartwatch-Guided home workouts
NCT ID NCT07611188
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a 12-week home exercise program, guided by a mobile app and smartwatch, can improve exercise capacity and quality of life in people with a left ventricular assist device (LVAD). About 78 participants who recently got an LVAD and cannot attend hospital rehab will be randomly assigned to either the home exercise program or usual care. The study will measure walking distance, safety, and emotional well-being.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 78 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
May 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2030
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria (must meet all): * Recent LVAD Implantation (\<6 months) * Clinical stability (defined as meeting all of the following criteria): discharge from the LVAD implantation hospitalization, absence of inotropic medication, hemoglobin \>9 g/dL, and no active infection. * Inability to participate in a supervised rehabilitation program (due to lack of availability, or inability because geographical reasons). Exclusion Criteria (any): * Functional Inability to Perform Cardiopulmonary Exercise Testing * Prior Participation in a Supervised Rehabilitation Program (after the LVAD implantation)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Advanced heart failure are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
10 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Complejo Hospitalario Universitario Santiago de Compostela
Santiago de Compostela, Galicia, 15706, Spain
-
Complejo Hospitalario Universitario de A Coruña
A Coruña, Galicia, 15006, Spain
-
Hospital 12 de Octubre
Madrid, Madrid, 28041, Spain
-
Hospital Clinic de Barcelona
Barcelona, Catalonia, 03036, Spain
-
Hospital Clinico San Carlos
Madrid, Madrid, 28040, Spain
-
Hospital Puerta de Hierro
Majadahonda, Madrid, 28028, Spain
-
Hospital Ramon y Cajal
Madrid, Madrid, 28034, Spain
-
Hospital Universitari de Bellvitge
Barcelona, Catalonia, Spain
-
Hospital Universitario de Salamanca
Salamanca, Castille and León, 37007, Spain
-
Hospital Virgen del Rocío
Seville, Andalusia, 41013, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can WhatsApp alerts tame blood sugar swings in kids with type 1 diabetes?
- Which SGLT2 inhibitor wins? trial pits empagliflozin against dapagliflozin
- Can a new care pathway speed up advanced heart failure decisions?
- Heart Disease's hidden toll: study tracks quality of life across mind, body, and spirit
- Can daily mindful breathing ease heart failure symptoms?
- Can a smartphone app keep heart failure patients out of the hospital?